Body Contouring Market is expected to See Incredible Growth by 2032

From 2022 to 2032, the body contouring market is expected to grow at a 6.9% CAGR, rising from US$ 7.3 billion in 2022 to US$ 11.1 billion in valuation by 2032.

Obesity cases in developed economies and around the world are expected to drive the global body contouring market. The increased safety and efficacy of these techniques, which improve the receiver's life expectancy and overall health, are expected to drive up demand for body contouring treatments.

North America and Europe are the top two markets for body contouring devices due to high population growth, obesity prevalence, high demand for aesthetic surgery, and high consumption of junk food. According to a 2018 report by the American Society of Plastic Surgeons, 56,018 body contouring procedures were performed in the United States following massive weight loss. The same report covers 258,558 liposuction procedures performed in the United States, indicating a trend that could boost market growth in this region.

Top Market Players:

Key players operating in the body contouring market are –

  • GlobalMed Technologies
  • Chromogenex, Human Med.
  • Wells Johnson Company
  • Invasix Aesthetic Solutions
  • Erchonia
  • Fotona
  • Cutera
  • BTL Industries
  • Meridian
  • Palomar Medical Technologies
  • Others

Key Market Segmentation Covered in the Study:

By Invasiveness:

  • Non-Invasive Contouring
  • Minimally Invasive Contouring
  • Invasive Contouring

By End-user:

  • Hospitals
  • Ambulatory surgical centers
  • Medical Spa
  • Clinics

By Regions:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Europe (Germany, Italy, France, U.K, Spain, , Russia)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, ASEAN)
  • Oceania (Australia, New Zealand)
  • Middle East and Africa (GCC Countries, South Africa, Northern Africa)

Read More@ https://www.futuremarketinsights.com/reports/body-contouring-market

Important changes in Market Dynamics:

The report has been created after detailed and exhaustive studies by the analysts at FMI taking several factors into consideration like monetary, ecological, social, mechanical, and political status of a particular demography. They study the key data to assess the revenue and production of manufacturers across various regions. The report also covers an in-depth analysis of the key changes in market dynamics in the recent past and the near future.

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more